Analysis of the Dynamics of a Tumor–Immune System with Chemotherapy and Immunotherapy and Quadratic Optimal Control

被引:38
作者
Sharma S. [1 ]
Samanta G.P. [1 ]
机构
[1] Department of Mathematics, Indian Institute of Engineering Science and Technology, Shibpur, Howrah
关键词
Chemotherapeutic drug; Immunotherapeutic drug; Optimal control; Stability; Tumor growth model;
D O I
10.1007/s12591-015-0250-1
中图分类号
学科分类号
摘要
In this paper, we consider a tumor growth model with the effect of tumor–immune interactions and chemotherapeutic as well as immunotherapeutic drugs. In our model there are four compartments, namely tumor cells, immune cells, chemotherapeutic drug concentration and immunotherapeutic drug concentration. The dynamical behaviour of our system by analyzing the existence and stability of our system at various equilibria is discussed elaborately. We set up an optimal control problem relative to the model so as to minimize the number of tumor cells and the chemotherapeutic and immunotherapeutic drugs administration. Here we use a quadratic control to quantify this goal and consider the administration of chemotherapy and immunotherapeutic drugs as controls to reduce the spread of the tumor growth. The important mathematical findings for the dynamical behaviour of the tumor–immune model are also numerically verified using MATLAB. Finally epidemiological implications of our analytical findings are addressed critically. © 2015, Foundation for Scientific Research and Technological Innovation.
引用
收藏
页码:149 / 171
页数:22
相关论文
共 41 条
[1]  
Arciero J.C., Jackson T.L., Kirschner D.E., A mathematical model of tumor-immune evasion and siRNA treatment, Discret. Cont. Dyn. Syst. Series B, 4, 1, pp. 39-58, (2004)
[2]  
Bellomo N., Bellouquid A., Delitala M., Mathematical topics on the modelling of multicellular systems in competition between tumor and immune cells, Math. Mod. Math. Appl. Sci., 14, (2004)
[3]  
Bellomo N., Preziosi L., Modelling and mathematical problems related to tumor evolution and its interaction with the immune system, Math. Comput. Model., 32, (2000)
[4]  
Blayneh K., Cao Y., Kwon H.D., Optimal control of vector-borne disease: treatment and prevention, Discret. Cont. Dyn. Sys. Series B, 11, pp. 1-31, (2009)
[5]  
Calabresi P., Schein P.S., Medical Oncology: Basic Principles and Clinical Management of Cancer, (1993)
[6]  
Chan B.S., Yu P., Bifurcation analysis in a model of cytotoxic T-lymphocyte response to viral infections, Nonlinear Anal.: Real World Appl., 13, pp. 64-77, (2012)
[7]  
de Pillis L.G., Gu W., Fister K.R., Head T., Maples K., Murugan A., Neal T., Yoshida K., Chemotherapy for tumors: an analysis of the dynamics and a study od quadratic and linear optimal controls, Math. Biosci., 209, pp. 292-315, (2007)
[8]  
de Pillis L.G., Gu W., Radunskaya A.E., Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations, J. Theo. Biol., 238, pp. 841-862, (2006)
[9]  
de Pillis L.G., Radunskaya A.E., A mathematical tumor model with immune resistance and drug therapy: an optimal control approach, J. Theor. Med., 3, (2001)
[10]  
de Pillis L.G., Radunskaya A.E., The dynamics of an optimally controlled tumor model: a case study, Math. Comp. Model., 37, pp. 1221-1244, (2003)